Strategies to prevent anaemia in preterm newborns include drawing fewer blood samples, the use of recombinant human erythropoietin and iron supplementation. Although iron sulphate is the most commonly used pharmaceutical formulation for iron supplementation, there are few studies comparing different iron salts in newborns.

Iron supplementation with iron sulfate versus iron bisglycinate chelate in preterm infants

Boetti, Tatiana;Cester, Elena Andrea;Bertino, Enrico;
2018

Abstract

Strategies to prevent anaemia in preterm newborns include drawing fewer blood samples, the use of recombinant human erythropoietin and iron supplementation. Although iron sulphate is the most commonly used pharmaceutical formulation for iron supplementation, there are few studies comparing different iron salts in newborns.
CURRENT PEDIATRIC REVIEWS
1
10
haemoglobin; iron bisglycinate chelate; iron sulfate; preterm newborn anaemia; treatment
Bagna, Rossana; Spada, Elena; Mazzone, Raffaella; Saracco, Paola; Boetti, Tatiana; Cester, Elena Andrea; Bertino, Enrico; Coscia, Alessandra
File in questo prodotto:
File Dimensione Formato  
2nd Bagna MS.pdf

non disponibili

Tipo di file: PDF EDITORIALE
Dimensione 784.14 kB
Formato Adobe PDF
784.14 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1660374
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 10
social impact